We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo ADLM 2026 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Genome Express in Contract with Food Agency

By Labmedica staff writers
Posted on 18 Apr 2005
Under the terms of an agreement with the Centre Technique de la Conservation des Produits Agricole (CTCPA, Paris, France), Genome express (Grenoble, France; www. genome-express.com) will perform molecular biology analyses on food products.

The CTCPA is overseen by the Ministries for Agriculture and Economy and Finance and its mission is to aid the agri-food industry in the areas of food safety, technical innovation, and quality management. This follows the introduction of new regulations covering product labeling in Europe.

Using its Gextrack DNA analysis services, Genome express will detect allergenic ingredients, authenticate a product, and detect and identify genetically modified organisms (GMOs). Genome express specializes in DNA analysis for customers in human and animal healthcare, pharmaceuticals, agri-food, and academic research. Among the company's services are DNA sequencing, food ingredient specification, and bacterial identification.

"Subcontracting the identification of food content and origins to DNA analysis specialists rather than doing it ourselves is clearly to the benefit of our clients,” said Didier Bombe, director of the analysis department at CTCPA. "This agreement extends the range of services we can offer and will also open up other interesting developments using Genome express's technology and know-how,” said Didier Bombe, director of the analysis department at CTCPA.




Related Links:
Genome Express

Gold Member
Neonatal Heel Incision Device
Tenderfoot
Online QC Software
Acusera 24•7
Hematology Consumables
Bioblood Devices
New
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.

Latest Industry News

Collaboration Advances Extracellular Vesicle-Based Tests for Neurodegenerative Diseases
18 Apr 2005  |   Industry

Tempus to Acquire Personalis in $1.5 Billion Precision Oncology Deal
18 Apr 2005  |   Industry

Bruker Expands NGS Capabilities for Sepsis and Bloodstream Infections
18 Apr 2005  |   Industry



PURITAN MEDICAL